News from the group: New CEO at SWATAB

News from the Group: Buvidal® Weekly and Buvidal® Monthly (CAM2038) approved in Australia as the first long-acting treatment of opioid dependence

Camurus announced today that the Australian Therapeutic Goods Administration (TGA) has approved the company’s lead products Buvidal® Weekly and Buvidal® Monthly (CAM2038) for maintenance treatment of opioid dependence within a framework of medical, social and psychosocial support.

News from the Group: Camurus receives EU approval for Buvidal®

Camurus receives EU approval for weekly and monthly Buvidal® (CAM2038) for opioid dependence. Buvidal® is the first long-acting medicine approved in the EU for the treatment of opioid dependence in adults and adolescents.

News from the Group: Camurus Interim Report January-September 2018

“Following the positive CHMP opinion for Buvidal®, we have ramped up our commercial activities and are ready for launch in the first wave European markets”, Fredrik Tiberg, President and CEO, says in his CEO comments.

News from the Group: Spin-off of Solo Rescue from GRANULDISK

News from Sandberg Development: Sandberg Development invests in water technology company SWATAB

The family owned investment company Sandberg Development invests in SWATAB (SCANDINAVIAN WATER TECHNOLOGY AB). The investment implies a growth venture with an upscaling of the organization and production, which will be built in Sandberg Development’s premises in Malmö.

News from Sandberg Development: We have updated our privacy policy

On the 25th of May 2018 the new regulation in EU law on data protection and privacy for all individuals within the European Union, GDPR, was implemented. In connection with this we updated our privacy policy. Please see the complete policy below.

News from Sandberg Development: Refurbishment of production and office facilities

News from Sandberg Development: Sandberg Development sponsor of Star for Life

From 2015 Sandberg Development is a sponsor of Star for Life, an educational/motivational programme, the aim of which is to strengthen the self esteem of young people and to counter the spread of HIV/AIDS.

News from the Group: Camurus's initial public offering a success

On Thursday December 3, 2015, Camurus started its first day of trading on Nasdaq Stockholm. The share price increased considerably during the first day and Camurus is now the largest company in the biotechnology sector on Nasdaq Stockholm

News from Sandberg Development: New CFO at Sandberg Development

News from the Group: Major GRANULDISK investment - inauguration of new production facility in Malmö

GRANULDISK recently moved into new facilities in Malmö. The history behind the large-scale investment is strong growth in Sweden and Europe and increased demand, not least from Asia and the Middle East. The company has recruited about ten new employees and expects to recruit more in the longer run.

News from Sandberg Development: GS Development changes its name to Sandberg Development AB

In the wake of an extensive branding process, GS Development is changing its name to Sandberg Development AB. This process was initiated to clarify its communications so that they reflect the group’s focus on world-class innovations.